Nrx Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Nrx Pharmaceuticals shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Nrx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Nrx Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Nrx Pharmaceuticals by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $7.8k | 17k | 0.47 |
2023-12-31 | $22k | 47k | 0.46 |
2023-09-30 | $314 | 1.2k | 0.26 |
2023-06-30 | $1.3k | 2.8k | 0.48 |
2023-03-31 | $12k | 19k | 0.66 |
2022-12-31 | $433 | 390 | 1.11 |
2022-06-30 | $10k | 17k | 0.60 |
2022-03-31 | $11k | 4.5k | 2.43 |
2021-12-31 | $53k | 12k | 4.52 |
2021-06-30 | $97k | 8.4k | 11.57 |
Top funds holding Nrx Pharmaceuticals
View all funds holding Nrx Pharmaceuticals